Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 300

1.

Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters.

Tondo L, Abramowicz M, Alda M, Bauer M, Bocchetta A, Bolzani L, Calkin CV, Chillotti C, Hidalgo-Mazzei D, Manchia M, Müller-Oerlinghausen B, Murru A, Perugi G, Pinna M, Quaranta G, Reginaldi D, Reif A, Ritter P Jr, Rybakowski JK, Saiger D, Sani G, Selle V, Stamm T, Vázquez GH, Veeh J, Vieta E, Baldessarini RJ.

Int J Bipolar Disord. 2017 Dec;5(1):27. doi: 10.1186/s40345-017-0096-2. Epub 2017 Aug 1.

2.

[Genetic tests for controlling treatment with antidepressants].

Bschor T, Baethge C, Hiemke C, Müller-Oerlinghausen B.

Nervenarzt. 2017 May;88(5):495-499. doi: 10.1007/s00115-017-0310-6. German.

PMID:
28303314
3.

Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depression.

Abou-Saleh MT, Müller-Oerlinghausen B, Coppen AJ.

Int J Bipolar Disord. 2017 Dec;5(1):11. doi: 10.1186/s40345-017-0080-x. Epub 2017 May 8. Review.

4.

[Psychopharmaceuticals for treatment of suicidal patients and for suicide prevention].

Haußmann R, Bauer M, Lewitzka U, Müller-Oerlinghausen B.

Nervenarzt. 2016 May;87(5):483-7. doi: 10.1007/s00115-016-0088-y. Review. German.

PMID:
26952239
5.

The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review.

Lewitzka U, Severus E, Bauer R, Ritter P, Müller-Oerlinghausen B, Bauer M.

Int J Bipolar Disord. 2015 Dec;3(1):32. doi: 10.1186/s40345-015-0032-2. Epub 2015 Jul 18.

6.

[New facts of long-term prophylaxis for bipolar affective disorder].

Bschor T, Müller-Oerlinghausen B, Stoppe G, Hiemke C.

Nervenarzt. 2014 Sep;85(9):1166-70. doi: 10.1007/s00115-014-4083-x. German.

PMID:
24943361
7.

[S3 guidelines on bipolar disorders are contemporary and important instruments for clinical practice. Against].

Grof P, Müller-Oerlinghausen B.

Nervenarzt. 2013 Jul;84(7):876-8. doi: 10.1007/s00115-013-3797-5. German. No abstract available.

PMID:
23709049
8.

[First check the evidence--then recommend therapy].

Ujeyl M, Müller-Oerlinghausen B.

Schmerz. 2013 Apr;27(2):202-4. doi: 10.1007/s00482-013-1316-z. German. No abstract available.

PMID:
23588802
9.

Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients.

Berghöfer A, Alda M, Adli M, Baethge C, Bauer M, Bschor T, Grof P, Müller-Oerlinghausen B, Rybakowski JK, Suwalska A, Pfennig A.

Int J Bipolar Disord. 2013 Jul 31;1:11. doi: 10.1186/2194-7511-1-11. eCollection 2013.

10.

[Antipsychotics for treatment of neuropsychiatric disorders in dementia].

Gertz HJ, Stoppe G, Müller-Oerlinghausen B, Schmidt LG, Baethge C, Hiemke C, Lieb K, Bschor T.

Nervenarzt. 2013 Mar;84(3):370-3. doi: 10.1007/s00115-012-3693-4. German.

PMID:
23242013
11.

Commentary on a recent review of lithium toxicity: what are its implications for clinical practice?

Müller-Oerlinghausen B, Bauer M, Grof P.

BMC Med. 2012 Nov 2;10:132. doi: 10.1186/1741-7015-10-132.

12.

[Antidepressants for treatment of depression in palliative patients : a systematic literature review].

Ujeyl M, Müller-Oerlinghausen B.

Schmerz. 2012 Sep;26(5):523-36. doi: 10.1007/s00482-012-1221-x. Review. German.

PMID:
22968366
13.

[Are atypical antipsychotic drugs the first line treatment for bipolar disorders? Against].

Müller-Oerlinghausen B.

Nervenarzt. 2012 Sep;83(9):1191-2. doi: 10.1007/s00115-012-3619-1. German. No abstract available.

PMID:
22911321
14.

[Anti-suicidal effect of lithium: current state of research and its clinical implications for the long-term treatment of affective disorders].

Lewitzka U, Bauer M, Felber W, Müller-Oerlinghausen B.

Nervenarzt. 2013 Mar;84(3):294-306. doi: 10.1007/s00115-012-3542-5. Review. German.

PMID:
22528065
15.

General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein D, Versiani M, Möller HJ; Section of Pharmacopsychiatry, World Psychiatric Association.

Eur Arch Psychiatry Clin Neurosci. 2011 Nov;261 Suppl 3:207-45. doi: 10.1007/s00406-011-0259-6.

PMID:
22033583
16.

[Psychotherapy should be verifiable too].

Müller-Oerlinghausen B.

MMW Fortschr Med. 2011 Sep 29;153(39):30. German. No abstract available.

PMID:
21991832
17.

Correspondence (letter to the editor): Cooperation of all participating groups.

Müller-Oerlinghausen B, Aly AF.

Dtsch Arztebl Int. 2010 Aug;107(31-32):558-9; author reply 559-60. doi: 10.3238/arztebl.2010.0558b. Epub 2010 Aug 9. No abstract available.

18.

Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project.

Stübner S, Grohmann R, von Stralendorff I, Rüther E, Möller HJ, Müller-Oerlinghausen B, Engel RR, Horvath A, Greil W.

J Clin Psychiatry. 2010 Oct;71(10):1293-307. doi: 10.4088/JCP.09m05912blu. Epub 2010 Aug 10.

PMID:
20816032
19.

Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders.

Pfennig A, Schlattmann P, Alda M, Grof P, Glenn T, Müller-Oerlinghausen B, Suwalska A, Rybakowski J, Willich SN, Bauer M, Berghöfer A.

Bipolar Disord. 2010 Jun;12(4):390-6. doi: 10.1111/j.1399-5618.2010.00826.x.

PMID:
20636636
20.

Lithium reduces pathological aggression and suicidality: a mini-review.

Müller-Oerlinghausen B, Lewitzka U.

Neuropsychobiology. 2010;62(1):43-9. doi: 10.1159/000314309. Epub 2010 May 7. Review.

PMID:
20453534

Supplemental Content

Loading ...
Support Center